TY  - GEN
AU  - Medina-Vera, Dina
AU  - Rosell-Valle, Cristina
AU  - López-Gambero, Antonio J.
AU  - Navarro, Juan A.
AU  - Zambrana-Infantes, Emma N.
AU  - Rivera, Patricia
AU  - Santín, Luis J.
AU  - Suarez, Juan
AU  - Rodríguez de Fonseca, Fernando
PY  - 2020
DO  - 10.3390/biology9110377
UR  - http://hdl.handle.net/20.500.12105/18148
AB  - Alzheimer's disease (AD) is the most common form of neurodegeneration and dementia. The endocannabinoid (ECB) system has been proposed as a novel therapeutic target to treat AD. The present study explores the expression of the ECB system, the...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - Alzheimer’s disease
KW  - 5xFAD
KW  - Endocannabinoid system
KW  - Amyloid-β
KW  - Neuroinflammation
KW  - GPR55
KW  - Enfermedad de Alzheimer
KW  - Enfermedades neuroinflamatorias
KW  - Péptidos beta-amiloides
KW  - Endocannabinoides
KW  - Animals
KW  - Mice
KW  - Alzheimer Disease
KW  - Monoacylglycerol Lipases
KW  - Endocannabinoids
KW  - Flavin-Adenine Dinucleotide
KW  - Lipoprotein Lipase
KW  - Receptor, Cannabinoid, CB2
KW  - Receptor, Cannabinoid, CB1
KW  - Performance Anxiety
KW  - Mice, Transgenic
KW  - Hippocampus
KW  - Cognition
KW  - Cannabinoids
TI  - Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer's Disease in a Preclinical Model: A Therapeutic Opportunity
TY  - research article
ER  -